Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.

Anckaerts C, Blockx I, Summer P, Michael J, Hamaide J, Kreutzer C, Boutin H, Couillard-Després S, Verhoye M, Van der Linden A.

Neurobiol Dis. 2019 Apr;124:93-107. doi: 10.1016/j.nbd.2018.11.010. Epub 2018 Nov 13.

PMID:
30445024
2.

Infection Augments Expression of Mechanosensing Piezo1 Channels in Amyloid Plaque-Reactive Astrocytes.

Velasco-Estevez M, Mampay M, Boutin H, Chaney A, Warn P, Sharp A, Burgess E, Moeendarbary E, Dev KK, Sheridan GK.

Front Aging Neurosci. 2018 Oct 22;10:332. doi: 10.3389/fnagi.2018.00332. eCollection 2018.

3.

In vivo molecular imaging of neuroinflammation in Alzheimer's disease.

Chaney A, Williams SR, Boutin H.

J Neurochem. 2019 May;149(4):438-451. doi: 10.1111/jnc.14615. Epub 2018 Nov 26. Review.

4.

Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats.

Dickie BR, Vandesquille M, Ulloa J, Boutin H, Parkes LM, Parker GJM.

Neuroimage. 2019 Jan 1;184:349-358. doi: 10.1016/j.neuroimage.2018.09.030. Epub 2018 Sep 13.

PMID:
30219292
5.

Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry.

Henderson F, Hart PJ, Pradillo JM, Kassiou M, Christie L, Williams KJ, Boutin H, McMahon A.

Rapid Commun Mass Spectrom. 2018 May 15;32(9):721-729. doi: 10.1002/rcm.8090.

PMID:
29484723
6.

Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe ×PS1Δe9 transgenic mouse model of Alzheimer's disease.

Chaney A, Bauer M, Bochicchio D, Smigova A, Kassiou M, Davies KE, Williams SR, Boutin H.

J Neurochem. 2018 Feb;144(3):318-335. doi: 10.1111/jnc.14251. Epub 2017 Dec 15.

7.

Development of a method for the preparation of zirconium-89 radiolabelled chitosan nanoparticles as an application for leukocyte trafficking with positron emission tomography.

Fairclough M, Ellis B, Boutin H, Jones AKP, McMahon A, Alzabin S, Gennari A, Prenant C.

Appl Radiat Isot. 2017 Dec;130:7-12. doi: 10.1016/j.apradiso.2017.09.004. Epub 2017 Sep 6.

PMID:
28923298
8.

Acoustic dissipation in wooden pipes of different species used in wind instrument making: An experimental study.

Boutin H, Le Conte S, Vaiedelich S, Fabre B, Le Carrou JL.

J Acoust Soc Am. 2017 Apr;141(4):2840. doi: 10.1121/1.4981119.

PMID:
28464673
9.

Mass spectrometry imaging shows major derangements in neurogranin and in purine metabolism in the triple-knockout 3×Tg Alzheimer mouse model.

Esteve C, Jones EA, Kell DB, Boutin H, McDonnell LA.

Biochim Biophys Acta Proteins Proteom. 2017 Jul;1865(7):747-754. doi: 10.1016/j.bbapap.2017.04.002. Epub 2017 Apr 11.

PMID:
28411106
10.

FTIR imaging of the molecular burden around Aβ deposits in an early-stage 3-Tg-APP-PSP1-TAU mouse model of Alzheimer's disease.

Surowka AD, Pilling M, Henderson A, Boutin H, Christie L, Szczerbowska-Boruchowska M, Gardner P.

Analyst. 2016 Dec 19;142(1):156-168.

PMID:
27917428
11.

Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia.

Pradillo JM, Murray KN, Coutts GA, Moraga A, Oroz-Gonjar F, Boutin H, Moro MA, Lizasoain I, Rothwell NJ, Allan SM.

Brain Behav Immun. 2017 Mar;61:117-126. doi: 10.1016/j.bbi.2016.11.013. Epub 2016 Nov 14.

12.

Development & automation of a novel [(18)F]F prosthetic group, 2-[(18)F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide.

Morris O, Gregory J, Kadirvel M, Henderson F, Blykers A, McMahon A, Taylor M, Allsop D, Allan S, Grigg J, Boutin H, Prenant C.

Appl Radiat Isot. 2016 Oct;116:120-7. doi: 10.1016/j.apradiso.2016.07.023. Epub 2016 Jul 27.

13.

Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats.

Sridharan S, Lepelletier FX, Trigg W, Banister S, Reekie T, Kassiou M, Gerhard A, Hinz R, Boutin H.

Mol Imaging Biol. 2017 Feb;19(1):77-89. doi: 10.1007/s11307-016-0984-3.

14.

Automation of [(18) F]fluoroacetaldehyde synthesis: application to a recombinant human interleukin-1 receptor antagonist (rhIL-1RA).

Morris O, McMahon A, Boutin H, Grigg J, Prenant C.

J Labelled Comp Radiopharm. 2016 Jun 15;59(7):277-83. doi: 10.1002/jlcr.3393. Epub 2016 Apr 6.

15.

A new technique for the radiolabelling of mixed leukocytes with zirconium-89 for inflammation imaging with positron emission tomography.

Fairclough M, Prenant C, Ellis B, Boutin H, McMahon A, Brown G, Locatelli P, Jones AK.

J Labelled Comp Radiopharm. 2016 Jun 15;59(7):270-6. doi: 10.1002/jlcr.3392. Epub 2016 Apr 8.

16.

Early changes in extracellular matrix in Alzheimer's disease.

Lepelletier FX, Mann DM, Robinson AC, Pinteaux E, Boutin H.

Neuropathol Appl Neurobiol. 2017 Feb;43(2):167-182. doi: 10.1111/nan.12295. Epub 2015 Nov 30.

PMID:
26544797
17.

Laryngeal flow due to longitudinal sweeping motion of the vocal folds and its contribution to auto-oscillation.

Boutin H, Smith J, Wolfe J.

J Acoust Soc Am. 2015 Jul;138(1):146-9. doi: 10.1121/1.4922470.

PMID:
26233015
18.

Relationships between pressure, flow, lip motion, and upstream and downstream impedances for the trombone.

Boutin H, Fletcher N, Smith J, Wolfe J.

J Acoust Soc Am. 2015 Mar;137(3):1195-209. doi: 10.1121/1.4908236.

PMID:
25786934
19.

18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke.

Boutin H, Murray K, Pradillo J, Maroy R, Smigova A, Gerhard A, Jones PA, Trigg W.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):503-11. doi: 10.1007/s00259-014-2939-8. Epub 2014 Oct 29.

PMID:
25351507
20.

Producing undistorted acoustic sine waves.

Boutin H, Smith J, Wolfe J.

J Acoust Soc Am. 2014 Apr;135(4):1665-7. doi: 10.1121/1.4868374.

PMID:
25234964
21.

[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats.

Boutin H, Prenant C, Maroy R, Galea J, Greenhalgh AD, Smigova A, Cawthorne C, Julyan P, Wilkinson SM, Banister SD, Brown G, Herholz K, Kassiou M, Rothwell NJ.

PLoS One. 2013;8(2):e56441. doi: 10.1371/journal.pone.0056441. Epub 2013 Feb 13.

22.

Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.

Pradillo JM, Denes A, Greenhalgh AD, Boutin H, Drake C, McColl BW, Barton E, Proctor SD, Russell JC, Rothwell NJ, Allan SM.

J Cereb Blood Flow Metab. 2012 Sep;32(9):1810-9. doi: 10.1038/jcbfm.2012.101. Epub 2012 Jul 11.

23.

Contribution of interleukin-1 receptor accessory protein B to interleukin-1 actions in neuronal cells.

Nguyen L, Rothwell NJ, Pinteaux E, Boutin H.

Neurosignals. 2011;19(4):222-30. doi: 10.1159/000330803. Epub 2011 Sep 28.

24.

Assessing the contribution of inflammation in models of Alzheimer's disease.

Johnston H, Boutin H, Allan SM.

Biochem Soc Trans. 2011 Aug;39(4):886-90. doi: 10.1042/BST0390886. Review.

PMID:
21787318
25.

Brain inflammation is induced by co-morbidities and risk factors for stroke.

Drake C, Boutin H, Jones MS, Denes A, McColl BW, Selvarajah JR, Hulme S, Georgiou RF, Hinz R, Gerhard A, Vail A, Prenant C, Julyan P, Maroy R, Brown G, Smigova A, Herholz K, Kassiou M, Crossman D, Francis S, Proctor SD, Russell JC, Hopkins SJ, Tyrrell PJ, Rothwell NJ, Allan SM.

Brain Behav Immun. 2011 Aug;25(6):1113-22. doi: 10.1016/j.bbi.2011.02.008. Epub 2011 Feb 26.

26.

Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [¹⁸F]-IL1RA and PET imaging in rats.

Cawthorne C, Prenant C, Smigova A, Julyan P, Maroy R, Herholz K, Rothwell N, Boutin H.

Br J Pharmacol. 2011 Feb;162(3):659-72. doi: 10.1111/j.1476-5381.2010.01068.x.

27.

In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa).

Chauveau F, Boutin H, Van Camp N, Thominiaux C, Hantraye P, Rivron L, Marguet F, Castel MN, Rooney T, Benavides J, Dollé F, Tavitian B.

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):509-14. doi: 10.1007/s00259-010-1628-5. Epub 2010 Oct 9.

PMID:
20936410
28.

Interleukin-1 receptor antagonist in animal models of stroke: a fair summing up?

Parry-Jones A, Boutin H, Denes A, McColl B, Hopkins S, Allan S, Tyrrell P.

J Stroke Cerebrovasc Dis. 2010 Nov-Dec;19(6):512-3. doi: 10.1016/j.jstrokecerebrovasdis.2010.01.005. Epub 2010 Jul 10. No abstract available.

PMID:
20621515
29.

Radiolabeling with fluorine-18 of a protein, interleukin-1 receptor antagonist.

Prenant C, Cawthorne C, Fairclough M, Rothwell N, Boutin H.

Appl Radiat Isot. 2010 Sep;68(9):1721-7. doi: 10.1016/j.apradiso.2010.04.007. Epub 2010 Apr 21.

PMID:
20435481
30.

In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model.

Van Camp N, Boisgard R, Kuhnast B, Thézé B, Viel T, Grégoire MC, Chauveau F, Boutin H, Katsifis A, Dollé F, Tavitian B.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):962-72. doi: 10.1007/s00259-009-1353-0. Epub 2010 Jan 13.

PMID:
20069292
31.

Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.

Chauveau F, Van Camp N, Dollé F, Kuhnast B, Hinnen F, Damont A, Boutin H, James M, Kassiou M, Tavitian B.

J Nucl Med. 2009 Mar;50(3):468-76. doi: 10.2967/jnumed.108.058669. Epub 2009 Feb 17.

32.

Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Chauveau F, Boutin H, Van Camp N, Dollé F, Tavitian B.

Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2304-19. doi: 10.1007/s00259-008-0908-9. Epub 2008 Oct 1. Review.

PMID:
18828015
33.

Asthma counselling targeted to removal of domestic animals.

Hagan L, Valois P, Patenaude H, Boutin H, Boulet LP, Lafrenière F.

Can Respir J. 2008 Jan-Feb;15(1):33-8.

34.

Binding of an aptamer to the N-terminal fragment of VCAM-1.

Chauveau F, Aissouni Y, Hamm J, Boutin H, Libri D, Ducongé F, Tavitian B.

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6119-22. Epub 2007 Sep 15.

PMID:
17905582
35.

In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors.

Boutin H, Chauveau F, Thominiaux C, Kuhnast B, Grégoire MC, Jan S, Trebossen R, Dollé F, Tavitian B, Mattner F, Katsifis A.

Glia. 2007 Nov 1;55(14):1459-68.

PMID:
17680643
36.

Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice.

Boutin H, Catherine A, Mackenzie ET, Jauzac P, Dauphin F.

Acta Neuropathol. 2007 Nov;114(5):491-500. Epub 2007 Aug 4.

PMID:
17676326
37.

11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation.

Boutin H, Chauveau F, Thominiaux C, Grégoire MC, James ML, Trebossen R, Hantraye P, Dollé F, Tavitian B, Kassiou M.

J Nucl Med. 2007 Apr;48(4):573-81.

38.

Impact of a continuing education activity on the quality of telephone interventions by nurses in an adult asthma client base.

Boutin H, Robichaud P, Valois P, Labrecque M.

J Nurs Care Qual. 2006 Oct-Dec;21(4):335-43.

PMID:
16985404
39.

Improved synthesis of the peripheral benzodiazepine receptor ligand [11C]DPA-713 using [11C]methyl triflate.

Thominiaux C, Dollé F, James ML, Bramoullé Y, Boutin H, Besret L, Grégoire MC, Valette H, Bottlaender M, Tavitian B, Hantraye P, Selleri S, Kassiou M.

Appl Radiat Isot. 2006 May;64(5):570-3. Epub 2006 Jan 20.

PMID:
16427784
40.

Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia.

Pinteaux E, Rothwell NJ, Boutin H.

Glia. 2006 Apr 1;53(5):551-6.

PMID:
16374779
41.

Evaluation of a program aimed at increasing referrals for asthma education of patients consulting at the emergency department for acute asthma.

Robichaud P, Laberge A, Allen MF, Boutin H, Rossi C, Lajoie P, Boulet LP.

Chest. 2004 Nov;126(5):1495-501.

PMID:
15539718
42.

The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Boutin H, Kimber I, Rothwell NJ, Pinteaux E.

Mol Neurobiol. 2003 Jun;27(3):239-48. Review.

PMID:
12845150
43.

Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration.

Patel HC, Boutin H, Allan SM.

Ann N Y Acad Sci. 2003 May;992:39-47. Review.

PMID:
12794045
44.

No role for interleukin-18 in acute murine stroke-induced brain injury.

Wheeler RD, Boutin H, Touzani O, Luheshi GN, Takeda K, Rothwell NJ.

J Cereb Blood Flow Metab. 2003 May;23(5):531-5.

PMID:
12771567
45.

Potential use of early alterations in mu and delta opioid receptors as a predictive index for delayed brain ischemic damage.

Boutin H, Jauzac P, MacKenzie ET, Dauphin F.

Neurobiol Dis. 2003 Jun;13(1):63-73.

PMID:
12758068
46.

[Living with asthma (part 2). Essential information for asthma control].

Boutin H, Lachance MC, Robichaud P.

Infirm Que. 2003 Jan-Feb;10(3):12, 28-30. French. No abstract available.

PMID:
12645452
47.

[Living with asthma. (Part 1) Evaluation of the asthmatic crisis].

Boutin H, Lachance MC, Robichaud P.

Infirm Que. 2002 Nov-Dec;10(2):26, 48-50. French. No abstract available.

PMID:
12567838
48.

Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor.

Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N.

J Neurosci. 2002 Jan 1;22(1):38-43.

49.

Role of IL-1alpha and IL-1beta in ischemic brain damage.

Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ.

J Neurosci. 2001 Aug 1;21(15):5528-34. Erratum in: J Neurosci 2001 Sep 1;21(17):1a.

50.

Influence of asthma education on asthma severity, quality of life and environmental control.

Côté J, Cartier A, Robichaud P, Boutin H, Malo JL, Rouleau M, Boulet LP.

Can Respir J. 2000 Sep-Oct;7(5):395-400.

Supplemental Content

Loading ...
Support Center